Close

Dr Sedona Sweeney

Assistant Professor
in Health Economics

Room
327

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Tel.
020 7927 2890

Sedona has nine years’ experience in economic evaluation in low- and middle-income countries. Her research focuses on the improving understanding of the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV.

She is a member of the Task Force on Catastrophic Cost Measurement for TB, and is a co-investigator of the Value-TB project; a Bill and Melinda Gates funded multi-country costing study of TB interventions. She is also involved with the Global Health Costing Consortium, in which she focuses on costing standards and methods.

ORCiD

ResearchGate profile

Affiliations

Faculty of Public Health and Policy
Department of Global Health and Development

Centres

Centre for Evaluation
Tuberculosis (TB) Centre

Teaching

Sedona teaches on the Economic Evaluation module for in-house students.  She also supervises HPPF students.

Research

Sedona's current research projects include:

  • VALUE-TB: a collaboration between LSHTM, University of Cape Town, and WHO aiming to collect cost data to facilitate decision-making for TB in five countries (incl. Kenya, Ethiopia, Philippines, India, and Russia)
  • the Global Health Cost Consortium: which aims to mitigate the TB and HIV epidemics by systematically improving the availability, quality, timing, relevance, interpretation, and use of cost information on HIV and tuberculosis (TB) programs and services
Past involvement in research projects includes:
  • the Integra Initiative: an analysis of integrated HIV and sexual and reproductive health services in Kenya and Swaziland
  • the Health Systems Chronic Disease project: a project aiming to improve the health systems response to chronic disease in Uganda and Tanzania
  • a project assessing the impact and cost-effectiveness of needle/syringe provision on hepatitis C transmission among people who inject drugs in the UK
  • the MERGE project: evaluating a model of scaling-up integrated TB and HIV services in South Africa
Research Area
Economic evaluation
Health systems
Sexual health
Social and structural determinants of health
Equity
Randomised controlled trials
Violence
Discipline
Health economics
Economics
Disease and Health Conditions
Syphilis
Cardiovascular disease
Chronic disease
HIV/AIDS
Sexually transmitted disease
Tuberculosis
Diabetes
Hepatitis
Non-communicable diseases
Country
China
Ethiopia
United Kingdom
India
Kenya
Philippines
Swaziland
Tanzania
Uganda
South Africa
Region
East Asia & Pacific (developing only)
Europe & Central Asia (all income levels)
Least developed countries: UN classification
Sub-Saharan Africa (developing only)